Xinjun He

Company: VesiCURE Therapeutics

Job title: Chief Scientific Officer & Senior Vice President

Bio:

Dr. He is the CSO & SVP at VesiCURE Therapeutics, a company focused on innovative exosome drug research and development platform. Dr. He holds a Ph.D. from the University of Oregon, USA, and was a postdoctoral researcher at Harvard University and the University of Southern California, and a visiting scholar at the University of Wurzburg in Germany.

Seminars:

Strengthening & Expanding siRNA Drug Capability via EV Delivery System 11:30 am

Building a leading chromatographic exosome purification capability for suspension and adherent cell cultures Developing a proprietary payload loading technologies for small interfering RNAs and active protein drugs. Therapeutically significant targets can be efficiently regulated in lung, skin and solid tumor disease models, paving the way for further clinical development NEW DATA!Read more

day: Pre-Conference Focus Day